| WKY |
ejection fraction |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
266.0 days-280.0 days |
16 |
38.5 |
% |
3.2 |
12.8 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100301 |
2460 |
| WKY |
heart left ventricle end-systolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
266.0 days-280.0 days |
16 |
9.1 |
mm |
0.4 |
1.6 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100310 |
2460 |
| WKY |
heart rate |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart pumping trait |
male |
266.0 days-280.0 days |
5 |
398.0 |
beats/min |
37.0 |
82.73 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100312 |
2460 |
| WKY |
heart ventricle septal wall thickness |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle wall thickness |
male |
238.0 days-252.0 days |
20 |
0.13 |
cm |
0.03 |
0.13 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100337 |
2460 |
| WKY |
heart left ventricle end-systolic diameter |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
238.0 days-252.0 days |
30 |
8.9 |
mm |
0.2 |
1.1 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100344 |
2460 |
| WKY |
heart left ventricle end-systolic diameter |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
238.0 days-252.0 days |
20 |
9.0 |
mm |
0.2 |
0.89 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100343 |
2460 |
| WKY |
ejection fraction |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
266.0 days-280.0 days |
32 |
40.5 |
% |
2.4 |
13.58 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100302 |
2460 |
| WKY |
ejection fraction |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
266.0 days-280.0 days |
5 |
86.8 |
% |
1.5 |
3.35 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100300 |
2460 |
| WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266.0 days-280.0 days |
32 |
18.0 |
% |
1.5 |
8.49 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100305 |
2460 |
| WKY |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266.0 days-280.0 days |
5 |
7.9 |
mm |
0.2 |
0.45 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100306 |
2460 |
| WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266.0 days-280.0 days |
32 |
10.6 |
mm |
0.3 |
1.7 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100308 |
2460 |
| WKY |
heart ventricle septal wall thickness |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle wall thickness |
male |
238.0 days-252.0 days |
12 |
0.14 |
cm |
0.01 |
0.03 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100336 |
2460 |
| WKY |
heart ventricle septal wall thickness |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle wall thickness |
male |
238.0 days-252.0 days |
30 |
0.1 |
cm |
0.0 |
0.02 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100338 |
2460 |
| WKY |
heart left ventricle fractional shortening |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238.0 days-252.0 days |
12 |
41.1 |
% |
3.0 |
10.39 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100348 |
2460 |
| WKY |
ejection fraction |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
238.0 days-252.0 days |
12 |
75.8 |
% |
3.9 |
13.51 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100351 |
2460 |
| WKY |
ejection fraction |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
238.0 days-252.0 days |
30 |
37.0 |
% |
1.4 |
7.67 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100353 |
2460 |
| WKY |
E/A wave ratio |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood flow trait |
male |
238.0 days-252.0 days |
20 |
1.61 |
null |
0.21 |
0.94 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100355 |
2460 |
| WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266.0 days-280.0 days |
16 |
16.8 |
% |
1.6 |
6.4 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100304 |
2460 |
| WKY |
heart posterior wall thickness |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle posterior wall thickness |
male |
238.0 days-252.0 days |
20 |
0.17 |
cm |
0.01 |
0.04 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100346 |
2460 |
| WKY |
heart posterior wall thickness |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle posterior wall thickness |
male |
238.0 days-252.0 days |
30 |
0.18 |
cm |
0.0 |
0.02 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100347 |
2460 |
| WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238.0 days-252.0 days |
20 |
15.1 |
% |
1.0 |
4.47 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100349 |
2460 |
| WKY |
ejection fraction |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
238.0 days-252.0 days |
20 |
35.5 |
% |
2.0 |
8.94 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100352 |
2460 |
| WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266.0 days-280.0 days |
16 |
10.8 |
mm |
0.3 |
1.2 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100307 |
2460 |
| WKY |
heart left ventricle end-systolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
266.0 days-280.0 days |
32 |
8.8 |
mm |
0.3 |
1.7 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100311 |
2460 |
| WKY |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238.0 days-252.0 days |
12 |
8.3 |
mm |
0.2 |
0.69 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100339 |
2460 |
| WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238.0 days-252.0 days |
30 |
15.8 |
% |
0.7 |
3.83 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100350 |
2460 |
| WKY |
E/A wave ratio |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood flow trait |
male |
238.0 days-252.0 days |
12 |
1.39 |
null |
0.15 |
0.52 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
e/a wave |
100354 |
2460 |
| WKY |
heart left ventricle fractional shortening |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266.0 days-280.0 days |
5 |
51.5 |
% |
1.7 |
3.8 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100303 |
2460 |
| WKY |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
266.0 days-280.0 days |
5 |
3.8 |
mm |
0.3 |
0.67 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100309 |
2460 |
| WKY |
heart rate |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart pumping trait |
male |
266.0 days-280.0 days |
16 |
362.0 |
beats/min |
31.0 |
124.0 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100313 |
2460 |
| WKY |
heart rate |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart pumping trait |
male |
266.0 days-280.0 days |
32 |
373.0 |
beats/min |
15.0 |
84.85 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100314 |
2460 |
| WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238.0 days-252.0 days |
20 |
10.6 |
mm |
0.2 |
0.89 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100340 |
2460 |
| WKY |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
238.0 days-252.0 days |
12 |
4.9 |
mm |
0.3 |
1.04 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100342 |
2460 |
| WKY |
heart posterior wall thickness |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle posterior wall thickness |
male |
238.0 days-252.0 days |
12 |
0.17 |
cm |
0.01 |
0.03 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100345 |
2460 |
| WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238.0 days-252.0 days |
30 |
10.6 |
mm |
0.1 |
0.55 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100341 |
2460 |
| WKY |
E/A wave ratio |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood flow trait |
male |
238.0 days-252.0 days |
30 |
1.85 |
null |
0.14 |
0.77 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100356 |
2460 |